Richard Philipson is the founder of Calliditas Therapeutics. He was previously the CMO of Calliditas Therapeutics. Based in Stockholm, Sweden.
Richard Philipson has over 25 years of industry experience and a successful track record in drug development, providing clinical leadership resulting in four product approvals, including in rare disease and gene therapy. He has expertise in building high-functioning teams, building pipelines, and executing clinical development programs across all phases of development, and brings in-depth knowledge of regulatory strategy in drug development. He was previously the CMO of Calliditas Therapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library